This clinician guide describes the development process, analysis and discussion of the available research while providing more complete information for health care decision-making.
The Canadian Centre on Substance Use and Addiction (CCSA) has released a resource focusing on substance use in ageing populations. The document covers the consequences of substance use in older adults, health conditions which might occur...
Seminal work from Australia identified these as the three pillars of medication-based treatment of drug dependence; they form the kernel of this bite’s exploration of organisational influences on these treatments. Ethos, dose, and...
This Clinical Guide provides comprehensive, national guidance for optimal management of pregnant and parenting women with opioid use disorder and their infants. The Clinical Guide helps healthcare professionals and patients determine the...
Rationale The goal of this guideline is to improve the quality of care and treatment outcomes for patients with alcohol use disorder (AUD), as defined by DSM-5 (American Psychiatric Association 2013). The guideline focuses specifically on...
Abstract Objective: To develop and encourage the adoption of clinical practice guidelines (CPGs) for smoking cessation in Canada by engaging stakeholders in the adaptation of existing high-quality CPGs using principles of the ADAPTE...
There is no more important document for doctors treating problem drug use in the UK than the so-called ‘Orange guidelines’. This major update will substantially inform judgements of what constitutes acceptable medical practice - should...
Often called the Orange Book, this is guidance for clinicians treating people with drug problems. This 2017 version offers new guidelines on: prison-based treatment new psychoactive substances and club drugs mental health co-morbidity...
Introduction This Guideis written for primary care and mental health clinicians. It has been produced by the National Institute on Alcohol Abuse and Alcoholism (NIAAA),a component of the National Institutes of Health, with guidance from...
This guideline represents a significant step toward improving the treatment and management of patients with substance use disorders (SUD) in the Department of Veterans Affairs (VA) and the Department of Defense (DoD). As with other clinical...